Medix Inc.
| Code | Sector | Market |
|---|---|---|
| 331A | Service | Standard |
| Date of listing approval | 2025/02/12 |
|---|---|
| Expected Date | 2025/03/19 |
| Lead Underwriter | Mizuho |
| Description |
| Listed Shares(total) | 2,300,000 |
|---|---|
| Trading Unit | 100 |
| New Shares | 500,000 |
| Existing Shares | 1,800,000 |
| Shares Outstanding | PreIPO 7,580,000.00 |
| PostIPO 8,080,000.00 | |
| Paid Up Capital | PreIPO Y75,800,000 |
| PostIPO | |
| Expected Pricing Date | 2025/02/27 |
| Book Building Start | 2025/03/03 |
| Book Building End | 2025/03/07 |
| Fix Date | 2025/03/10 |
| Offering Starts | 2025/03/11 |
| Offering Ends | 2025/03/14 |
| Expect Pricing | - |
| Notional PER (based on previous period) |
- |
| Offering Price | |
| Offering Price PER (based on previous period) |
- |
| Offering Price PBR (based on previous period) |
|
| Use of Funds Raised |
Financial Data
Units:Y1,000
| Fiscal Year End:2022/03 | ||
|---|---|---|
| Consolidated | Non-consolidated | |
| Revenue | - | 14,392,106 |
| Current Profit | - | 516,416 |
| Net Profit | - | 134,319 |
| Net Assets | - | 1,355,946 |
| Fiscal Year End:2023/03 | ||
|---|---|---|
| Consolidated | Non-consolidated | |
| Revenue | - | 4,273,010 |
| Current Profit | - | 815,454 |
| Net Profit | - | 401,833 |
| Net Assets | - | 1,729,736 |
| Fiscal Year End:2024/03 | ||
|---|---|---|
| Consolidated | Non-consolidated | |
| Revenue | - | 4,179,864 |
| Current Profit | - | 804,600 |
| Net Profit | - | 489,196 |
| Net Assets | - | 2,157,214 |
| Recent Quarter 2024/09 |
||
|---|---|---|
| Consolidated | Non-consolidated | |
| Revenue | - | 1,944,781 |
| Current Profit | - | 400,522 |
| Net Profit | - | 435,455 |
| Net Assets | - | 2,532,429 |
Per Share Units:Y1
| Fiscal Year End:2022/03 | ||
|---|---|---|
| Consolidated | Non-consolidated | |
| Dividend | 3.80 | |
| Net Earning | - | - |
| Equity | 18.24 | 178.88 |
| Fiscal Year End:2023/03 | ||
|---|---|---|
| Consolidated | Non-consolidated | |
| Dividend | 6.00 | |
| Net Earning | - | - |
| Equity | 53.01 | 228.20 |
| Fiscal Year End:2024/03 | ||
|---|---|---|
| Consolidated | Non-consolidated | |
| Dividend | 8.00 | |
| Net Earning | - | - |
| Equity | 64.85 | 286.48 |
| Fiscal Year End:Interim Results 2024/09 |
||
|---|---|---|
| Consolidated | Non-consolidated | |
| Dividend | ||
| Net Earning | - | 57.83 |
| Equity | - | - |
Comment
| ąŁOver allotment(345,000) |
Consolidated Subsidiaries
| Name | Address |
|---|
Underwriters
| Allocation | Underwriter | Tel |
|---|---|---|
| 0% | Nomura | 03-3211-1811 |
| 0% | Mizuho | 03-5208-3210 |
| 0% | Mitsubishi UFJ Morgan Stanley Securities Co., Ltd. | 03-6213-8500 |
| 0% | SBI SECURITIES Co.,Ltd. | 03-5562-7210 |
| 0% | Rakuten Securities | 03-6406-2681 |
| 0% | Monex | 03-4323-3800 |
| 0% | Matsui | 03-5216-0606 |
| 0% | Tokai Tokyo | 03-3566-8811 |
Data
| Date of incorporation | 1984/03/30 |
|---|---|
| Company address | Tokyo 101-0051 |
| Telephone | 03-5280-9471 |
| President | |
| Homepage | https://www.medix-inc.co.jp/ |
| Auditor | Shinjuku |
| Major Shareholders | |
|---|---|
| Shareholder Name | Ratio |
| 86.62% | |
| 39.88% | |
| 21.90% | |
| 10.47% | |
| 9.39% | |
| 7.23% | |
| 5.23% | |
| 1.29% | |
| 0.93% | |
| 0.87% | |
| 0.65% | |
| Number of Employees | 280 as of 2025/01/31 |
|---|---|
| Birth Date of Representative | 1957/05/27 |